MedPath

OLANZAPINE

OLANZAPINE

Approved
DIN Number

02385872

Drug Class

Human

Market Date

Jun 12, 2012

Company
HC

sivem pharmaceuticals ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02385872
AIG Number0128783003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AH03 OLANZAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

OLANZAPINEActive
Strength: 5 MG
Monograph: OLANZAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.